Philippines to acquire BrahMos. Targets China

BrahMos Aerospace Pvt Ltd's $374.9 million proposal for a Shore-based Anti-Ship Missile System Acquisition Project has been selected by the Philippines, boosting India's defence export potential.

Officials at BrahMos have received a Notice of Award from the Philippines' Department of National Defense. In order to respond to the award notice, BrahMos Aerospace had 10 days to do so. INS Visakhapatnam recently tested a naval version of the BrahMos developed by India and Russia.

Due to the epidemic, the Philippines was unable to deliver the BrahMos missiles on time. Indian defence equipment can be exported to Manila under a defence deal struck last year. India has received interest from countries in Southeast Asia including Vietnam and Indonesia in procuring BrahMos to protect their defence assets.

Recent improvements in India-Philippines relations include increased defence cooperation and a preferential trade agreement. As a result of this agreement, Manila received a $100 million defence-related LoC from India.

India's first significant military export is the BrahMos. As part of a collaborative effort, the United States has developed a supersonic missile that can be fired from both aircraft and submarines, as well as a lighter, longer-range version.

The United Arab Emirates (UAE) is one of several nearby countries to which India has been advertising its missile system. It's being marketed as a missile that can strike both land targets and sea-surface threats.

During bilateral conversations with friendly countries, Minister Rajnath Singh has made it a point to highlight a broad range of weaponry on offer from the military ministry. In order to promote Indian armaments overseas, certain alterations have been made to make exports easier.

Comments

Popular posts from this blog

Indigenous tank T-90 Bhishma rolls out

Second only to US IAF & Navy to get DRDO's CHAFF tech for protecting Aircrafts and Ships from enemy missile

India built N-sub in Kalpakkam under codename 'PRP'